Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer
暂无分享,去创建一个
C. Ishioka | S. Morita | Tatsuro Yamaguchi | M. Kurihara | Yasuhide Yamada | Y. Komatsu | M. Gamoh | A. Sato | S. Yuki | Shin Takahashi | K. Shimada | Rei Goto | Y. Yamada | R. Goto